Clinical Trial Update: A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the combination of mirabegron and solifenacin in adults with overactive bladder; the study is completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Mirabegron (mirabegron)
• Solifenacin (solifenacin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED | Results posted: 2018-02-28